Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders - PubMed (original) (raw)

Review

Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders

Brieana M Rowles et al. Dev Disabil Res Rev. 2010.

Abstract

Developmental disorders such as subaverage intelligence, pervasive developmental disorders, and genetic syndromes are frequently associated with comorbid attention-deficit/hyperactivity disorder (ADHD) or ADHD-like symptoms. While there are not pharmacological cures for these developmental disorders, coinciding ADHD and ADHD-like symptoms that contribute to difficulties in psychosocial functioning are frequently able to be addressed by pharmacotherapy. This article reviews what is known about the efficacy and tolerability of pharmacological interventions for the treatment of children and adolescents suffering from developmental disorders and comorbid ADHD/ADHD-like symptoms.

PubMed Disclaimer

Similar articles

• Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders.
  Weller EB, Rowan A, Elia J, Weller RA. Weller EB, et al. J Clin Psychiatry. 1999;60 Suppl 15:5-11. J Clin Psychiatry. 1999. PMID: 10418807 Review.
• Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
  Findling RL. Findling RL. Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Clin Ther. 2008. PMID: 18555941 Review.
• Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
  Research Units on Pediatric Psychopharmacology Autism Network. Research Units on Pediatric Psychopharmacology Autism Network. Arch Gen Psychiatry. 2005 Nov;62(11):1266-74. doi: 10.1001/archpsyc.62.11.1266. Arch Gen Psychiatry. 2005. PMID: 16275814 Clinical Trial.
• Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder.
  Kaplan G, Newcorn JH. Kaplan G, et al. Pediatr Clin North Am. 2011 Feb;58(1):99-120, xi. doi: 10.1016/j.pcl.2010.10.009. Pediatr Clin North Am. 2011. PMID: 21281851 Review.
• Attention-deficit-hyperactivity disorder: an update.
  Dopheide JA, Pliszka SR. Dopheide JA, et al. Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Pharmacotherapy. 2009. PMID: 19476419 Review.

Cited by

• Traditional Oriental Herbal Medicine for Children and Adolescents with ADHD: A Systematic Review.
  Wong YW, Kim DG, Lee JY. Wong YW, et al. Evid Based Complement Alternat Med. 2012;2012:520198. doi: 10.1155/2012/520198. Epub 2012 Dec 17. Evid Based Complement Alternat Med. 2012. PMID: 23346205 Free PMC article.
• The NKCC1 antagonist bumetanide mitigates interneuronopathy associated with ethanol exposure in utero.
  Skorput AG, Lee SM, Yeh PW, Yeh HH. Skorput AG, et al. Elife. 2019 Sep 23;8:e48648. doi: 10.7554/eLife.48648. Elife. 2019. PMID: 31545168 Free PMC article.
• Ningdong granule: a complementary and alternative therapy in the treatment of attention deficit/hyperactivity disorder.
  Li JJ, Li ZW, Wang SZ, Qi FH, Zhao L, Lv H, Li AY. Li JJ, et al. Psychopharmacology (Berl). 2011 Aug;216(4):501-9. doi: 10.1007/s00213-011-2238-z. Epub 2011 Mar 18. Psychopharmacology (Berl). 2011. PMID: 21416235 Clinical Trial.
• Natural Product-Derived Treatments for Attention-Deficit/Hyperactivity Disorder: Safety, Efficacy, and Therapeutic Potential of Combination Therapy.
  Ahn J, Ahn HS, Cheong JH, Dela Peña I. Ahn J, et al. Neural Plast. 2016;2016:1320423. doi: 10.1155/2016/1320423. Epub 2016 Feb 4. Neural Plast. 2016. PMID: 26966583 Free PMC article. Review.
• Effects of psychotropic drugs on second messenger signaling and preference for nicotine in juvenile male mice.
  Alcantara LF, Warren BL, Parise EM, Iñiguez SD, Bolaños-Guzmán CA. Alcantara LF, et al. Psychopharmacology (Berl). 2014 Apr;231(8):1479-92. doi: 10.1007/s00213-014-3434-4. Epub 2014 Jan 23. Psychopharmacology (Berl). 2014. PMID: 24452697 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Medical

  • MedlinePlus Health Information